Ameriprise Financial Inc Dyne Therapeutics, Inc. Transaction History
Ameriprise Financial Inc
- $375 Billion
- Q4 2024
A detailed history of Ameriprise Financial Inc transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 219,635 shares of DYN stock, worth $2.99 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
219,635
Previous 212,900
3.16%
Holding current value
$2.99 Million
Previous $7.65 Million
32.34%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding DYN
# of Institutions
213Shares Held
103MCall Options Held
135KPut Options Held
435K-
Atlas Venture Life Science Advisors, LLC8.02MShares$109 Million31.16% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$101 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.38MShares$100 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.7MShares$91.2 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.38MShares$86.8 Million2.43% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $705M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...